Namibia: Us Health Deal Faces Data Privacy Backlash in Namibia

What the report says

Namibia has rejected a proposed U.S. health data and biological specimen-sharing arrangement after legal review raised concerns about privacy, sovereignty and compliance with national law. According to The Namibian, government officials said the draft deal was tied to funding for HIV and tuberculosis programmes valued at more than N$145 million a year, and that parts of the proposal were judged inconsistent with Namibia’s legal requirements.

Officials said the main objections centered on access to medical information and control over biological resources. They also said the proposal appeared to bypass procedures such as export permits, prior informed consent and benefit-sharing rules. The U.S. government later withdrew the specimen-sharing component from funding talks in November 2025, but discussions over health data continued, with both sides still trying to resolve the broader agreement.

The issue matters because Namibia is seeking to protect health data and preserve its position in wider international negotiations on pathogen access and benefit-sharing under the World Health Organization framework. At the same time, the government says it is exploring alternative financing if no agreement is reached, including plans to secure about N$730 million for HIV-AIDS programmes in 2027.

The article also quotes Namibian lawmakers and former officials who supported the government’s stance, while a U.S. source told the newspaper that only aggregate data would be collected and that there was no request for personally identifiable information.